WebDoctor Encyclopedia

Primary bone tumours

Adamantinoma of bone

Adamantinoma is a rare, slow-growing malignant bone tumour that nearly always affects the shin bone (tibia) of teenagers and young adults. It is treated with wide surgical removal, and most people do well long term.

Medically reviewed Last reviewed October 17, 2026

What is adamantinoma of bone?

Adamantinoma is a rare, slow-growing, low-grade malignant bone tumour. In about nine out of ten cases it grows in the tibia (shin bone), usually in the middle part of the front of the bone, close to the skin. It sometimes also affects the neighbouring fibula.

The tumour is unusual because it contains epithelial cells, the kind of cells normally found in skin and glands, mixed with fibrous and bony tissue. Why epithelial cells appear inside bone is still not fully understood.

Adamantinoma mainly affects teenagers and young adults, most often between 10 and 40 years of age. It grows slowly over months or years and is often mistaken for a benign condition.

Despite its slow growth, adamantinoma can come back after incomplete removal and can spread to the lungs in some people. Wide surgical removal is therefore the main treatment (Qureshi et al., 2000).

The name “adamantinoma” is historical. The tumour resembles ameloblastoma, a jaw tumour once called adamantinoma, under the microscope, but the two are not related.

1. Key facts at a glance

Feature Details
Type of tumour Low-grade malignant bone tumour with epithelial and fibro-osseous parts
How common Very rare; under 1% of primary malignant bone tumours
Typical age Mostly 10-40; median about 25-35
Sex Slightly more common in men
Main site Front of the shaft of the tibia; sometimes the fibula as well
Types Classic adamantinoma and osteofibrous dysplasia-like (differentiated) adamantinoma
Main treatment Wide surgical removal with limb reconstruction
Outlook Good for most; about 85-90% alive at 10 years

2. Types of adamantinoma

There are two main forms, which differ in age, appearance and behaviour (Schutgens et al., 2020):

Type Typical age Features Behaviour
Classic adamantinoma Adults, mostly 20-50 Obvious islands and strands of epithelial cells Can recur and spread to lungs
Osteofibrous dysplasia-like adamantinoma Children and teenagers Mostly fibrous and bony tissue with only scattered epithelial cells Rarely spreads; may recur locally

Relationship with osteofibrous dysplasia

Osteofibrous dysplasia is a benign bone condition of the tibia in young children. It looks similar to adamantinoma on X-rays and under the microscope, but has no clusters of epithelial cells.

The three conditions are thought to form a spectrum, from benign osteofibrous dysplasia, through osteofibrous dysplasia-like adamantinoma, to classic adamantinoma (Most, Sim and Inwards, 2010). Whether one can turn into another is still debated.

3. Causes and risk factors

The cause of adamantinoma is not known.

Factor Notes
Age Most cases occur in adolescents and young adults
Previous injury Some patients recall a knock to the shin, but injury has not been shown to cause adamantinoma
Chromosome changes Extra copies of chromosomes 7, 8, 12, 19 and 21 are common in the tumour cells
Inheritance Not inherited

Adamantinoma is not infectious and is not linked to lifestyle factors. There is nothing a person could have done to prevent it.

4. How does it look

On the outside

Because the tibia lies just under the skin, adamantinoma often causes visible changes:

Sign What it looks like
Swelling on the front of the shin A firm, sometimes tender lump that grows slowly
Bowing of the leg The shin bone may curve forwards, especially in children
Skin over the lump Usually normal, sometimes stretched or slightly warm
Limp Because of pain or a weakened bone

On X-rays

X-rays usually show a typical pattern:

Feature Description
Location Front (anterior) outer layer, or cortex, of the middle of the tibia
Appearance Several well-defined, bubbly lucent areas, often called a “soap bubble” look
Edges Bands of hardened (sclerotic) bone around and between the bubbles
Length Often long, extending along the bone
Other lesions Separate smaller areas further along the tibia or in the fibula

On MRI

MRI shows the full length of the tumour, any extension into the marrow or soft tissue, and separate “skip” lesions. This is essential for planning surgery.

Under the microscope

The tumour contains groups of epithelial cells within fibrous tissue and small fragments of woven bone. The epithelial cells can form several patterns, including basaloid, tubular, spindle and squamous types.

Staining for keratins, proteins found in epithelial cells, shows these cells clearly and helps to separate adamantinoma from osteofibrous dysplasia and fibrous dysplasia.

5. Symptoms

Adamantinoma grows slowly, so symptoms often develop over months or even years before diagnosis.

Common symptoms

  • Swelling or a lump on the front of the shin
  • Pain, often mild, dull and intermittent at first
  • Tenderness when the shin is knocked or touched
  • Bowing of the lower leg
  • Limping or difficulty with sport and long walks
  • A fracture after minor injury, because the bone is weakened (in about a quarter of patients)

Symptoms of spread

Spread is uncommon and usually occurs late, sometimes many years after the original tumour. It may cause:

  • Cough or breathlessness, if the lungs are involved
  • Swollen lymph nodes in the groin

When to seek medical advice

See a doctor if you or your child has a lump on the shin that is growing, persistent shin pain, pain at night or bowing of the leg.

Seek prompt advice after a fracture from a minor injury, as this can be a sign of a weakened bone.

6. Diagnosis

Diagnosis should be made at a specialist bone tumour centre, because adamantinoma is easily confused with benign bone conditions.

Test Purpose
X-ray of the whole tibia and fibula Shows the typical appearance and any additional lesions
MRI of the whole leg bone Shows the extent of the tumour and skip lesions
CT of the chest Checks the lungs for spread
Bone scan or PET-CT Looks for other bone lesions
Core needle biopsy Confirms the diagnosis; planned by the surgical team
Keratin staining Identifies epithelial cells

The biopsy should be done by, or in close consultation with, the team who will perform the main operation. A poorly placed biopsy can make later surgery more difficult.

Conditions that can look similar

Condition How it differs
Osteofibrous dysplasia Benign; young children; no clusters of epithelial cells
Fibrous dysplasia Usually in the marrow cavity rather than the cortex; different genetic change (GNAS)
Non-ossifying fibroma Common benign lesion, often near the ends of bones
Metastatic carcinoma Older adults; known cancer elsewhere
Chronic infection (osteomyelitis) Inflammation and infection markers; different biopsy findings

7. Treatment

Surgery

Wide surgical removal, taking the tumour out with a margin of healthy bone, is the treatment of choice. Removing only the visible tumour (curettage or intralesional surgery) leads to a high rate of recurrence (Keeney et al., 1989; Qureshi et al., 2000).

Most patients can have limb-sparing surgery. The missing section of bone must then be reconstructed:

Reconstruction Details
Bone transport The bone is gradually lengthened with an external frame to fill the gap
Vascularised fibula graft Bone from the other leg, with its blood supply, is transferred
Donor bone (allograft) Bone from a donor, fixed with plates or a nail
Intercalary endoprosthesis A metal implant replacing the middle section of the bone
Combined techniques Donor bone with a vascularised graft for added strength and healing

Amputation is rarely needed today. It may be considered for very large tumours, repeated recurrence or failed reconstruction.

Osteofibrous dysplasia-like adamantinoma

For the osteofibrous dysplasia-like form in children, some surgeons use close observation or less extensive surgery, as it rarely spreads. Wide removal is still often recommended, because the tumour can come back.

Why the margin matters

Adamantinoma often spreads along the outer layer of the bone further than can be seen on an X-ray. Small separate deposits may also lie a few centimetres away from the main tumour.

Surgeons therefore plan the operation using MRI of the whole bone, and they aim to remove the tumour with a cuff of normal bone and tissue around it. A pathologist then checks the edges of the removed bone under the microscope to confirm that they are clear.

If the edges are not clear, a further operation may be recommended to reduce the risk of the tumour coming back.

Radiotherapy and chemotherapy

Adamantinoma does not respond well to radiotherapy or chemotherapy. These treatments are used only in special situations, such as spread to the lungs that cannot be removed.

Lung metastases can sometimes be removed by surgery.

Recovery and rehabilitation

Stage What to expect
After surgery A few days to a week in hospital
Weight bearing Usually limited for weeks to months while the bone heals
Physiotherapy Rebuilds strength, movement and walking
Return to activity Can take 6-12 months after major reconstruction
Complications Infection, non-healing of the graft, fracture of the graft, which may need further surgery

8. Outlook (prognosis)

Most people with adamantinoma have a good long-term outlook. Around 85-90% are alive 10 years after diagnosis (Qureshi et al., 2000; Schutgens et al., 2020).

Factor Effect
Wide surgical margins Much lower risk of recurrence
Osteofibrous dysplasia-like type Very low risk of spread
Classic type Higher risk of recurrence and spread
Intralesional surgery or incomplete removal High risk of recurrence
Recurrence Linked with a higher risk of later spread
Lung spread Poorer outlook, though the tumour often grows slowly even then

Spread to the lungs or lymph nodes affects about 10-20% of patients, sometimes many years after treatment.

9. Follow-up

Because recurrence and spread can happen late, follow-up is long term, often for at least 10 years.

Time after surgery Typical follow-up
First 2-3 years X-ray or MRI of the leg and chest X-ray or CT every 3-6 months
Years 3-5 Every 6 months
After 5 years Every year, often continuing for life

Adamantinoma in children

In children, the osteofibrous dysplasia-like type is more common. Treatment has to take account of the growing skeleton. Surgeons may choose reconstructions that allow for growth, or plan leg-lengthening procedures later.

Children and families are supported by paediatric orthopaedic oncology teams, physiotherapists and play specialists. Most children return to school and normal activities once the bone has healed.

10. Living with adamantinoma

  • Follow the rehabilitation plan to protect your reconstruction
  • Ask about sport and activity; many people return to walking, cycling and swimming
  • Report new pain or swelling in the leg, or a persistent cough
  • Seek support from bone cancer charities, especially during long recoveries
  • Keep follow-up appointments, even years later

11. Frequently asked questions

Question Answer
Is adamantinoma cancer? Yes, it is a low-grade malignant bone tumour, but it grows slowly
Will I need chemotherapy? Usually not; surgery is the main treatment
Will I keep my leg? Most people have limb-sparing surgery
Can it come back? Yes, especially after incomplete removal, which is why wide surgery is advised
Is it related to the jaw tumour ameloblastoma? No. The names are similar for historical reasons only
Why did it take so long to diagnose? Adamantinoma grows slowly and can look like benign bone conditions, so it is often recognised only after a biopsy

12. Questions to ask your care team

  • Which type of adamantinoma do I have?
  • How much bone will need to be removed?
  • Which reconstruction do you recommend, and why?
  • How long will recovery take, and when can I return to work, school or sport?
  • How long will I need follow-up?
  • What signs of recurrence or complications should I watch for?
  • Will I need physiotherapy, and where will it take place?

Resources

  1. Qureshi, A.A. et al. (2000) ‘Current trends in the management of adamantinoma of long bones: an international study’, Journal of Bone and Joint Surgery (American Volume), 82(8), pp. 1122-1131.
  2. Keeney, G.L. et al. (1989) ‘Adamantinoma of long bones: a clinicopathologic study of 85 cases’, Cancer, 64(3), pp. 730-737.
  3. Schutgens, E.M. et al. (2020) ‘Surgical outcome and oncological survival of osteofibrous dysplasia-like and classic adamantinomas: an international multicenter study of 318 cases’, Journal of Bone and Joint Surgery (American Volume), 102(19), pp. 1703-1713.
  4. Hazelbag, H.M. et al. (1994) ‘Adamantinoma of the long bones: a clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior’, Journal of Bone and Joint Surgery (American Volume), 76(10), pp. 1482-1499.
  5. Most, M.J., Sim, F.H. and Inwards, C.Y. (2010) ‘Osteofibrous dysplasia and adamantinoma’, Journal of the American Academy of Orthopaedic Surgeons, 18(6), pp. 358-366.
  6. Van Rijn, R. et al. (2006) ‘Adamantinoma in childhood: report of six cases and review of the literature’, Pediatric Radiology, 36(10), pp. 1068-1074.
  7. Papagelopoulos, P.J. et al. (2007) ‘Clinicopathological features, diagnosis, and treatment of adamantinoma of the long bones’, Orthopedics, 30(3), pp. 211-215.
  8. National Cancer Institute (2026) Adamantinoma. Available at: https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/adamantinoma (Accessed: October 2026).

Prepared by the editorial team, October 2026.